Inotiv (NOTV) 10-Q2020 Q2 Quarterly report

Filed: 14 May 20, 2:16pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Aid, Appendix, aware, Beth, care, central, China, combat, counteract, covenant, declared, degree, depression, Division, economy, eliminate, equivalent, essential, exacerbate, experienced, exposed, extreme, favor, forgiven, governmental, greatest, group, health, home, inability, introduction, legislation, Letter, lifesaving, mitigate, monetary, mortgage, national, nature, Notwithstanding, outbreak, pandemic, Paycheck, payroll, platform, PPP, precipitate, prepayment, preventive, proforma, Proxy, rapidly, receipt, recession, relief, SBA, schedule, school, shelter, show, solid, spread, step, stringent, subsided, subtraction, Taylor, therapy, Trump, unable, uncertainty, undertook, unprecedented, unpredictable, vaccine, view, volatility, xv

Removed: AMT, andfor, anticipate, begin, capitalizing, collective, commenced, Commercial, comparable, DMPK, feet, full, hiring, Missouri, open, permit, prepare, reach, refundable, regular, repealed, salary, Senior, signifcant, skill, track, Vice

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

NOTV similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certifications of Acting Principal Executive Officer

Pursuant to Section 906

Of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)

The undersigned, the President and Chief Executive Officer of Bioanalytical Systems Inc. (the “Company”), hereby certifies that, to the best of his knowledge:

(a)

the Form 10-Q Quarterly Report of the Company for the three and six months ended March 31, 2020 filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(b)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	By:	/s/ Robert W. Leasure, Jr.
		Robert W. Leasure, Jr. President and Chief Executive Officer Date: May 14, 2020

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.